Comparison of Mantoux and Tine Tuberculin Skin Tests in BCG-Vaccinated Children Investigated for Tuberculosis

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Pan, Wenli ^a,b,c   Matizirofa, Lyness ^c,d   Workman, Lesley ^c,d   Hawkridge, Tony ^e   Hanekom, Willem ^c,d   Mahomed, Hassan ^c,d   Hussey, Gregory ^c,d   Hatherill, Mark ^c,d  

^a Department of Health ^*  (China)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e Aeras Global TB Vaccine Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; INFANT; INSTRUMENTATION; LABORATORY DIAGNOSIS; MALE; METABOLISM; METHODOLOGY; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; REGRESSION ANALYSIS; REPRODUCIBILITY; SKIN; TUBERCULIN TEST; TUBERCULOSIS;

BCG VACCINE; CHILD, PRESCHOOL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SKIN; TUBERCULIN TEST; TUBERCULOSIS;

EID: 77951216235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008085     Document Type: Article

References (48)

1. Shingadia D, Novelli V, (2008) The tuberculin skin test: a hundred, not out? Arch Dis Child 93: 189-190.
2. Rosenthal SR, Nikurs L, Yordy E, Hoder B, Thorne M, (1965) The tuberculin tine test compared to the Mantoux test with 5, 10, and 100 tuberculin units. Pediatrics 36: 385-393.
3. Hesseling AC, Gie RP, (2007) Scoring systems for the diagnosis of childhood tuberculosis: are we making progress? Int J Tuberc Lung Dis 11: 245.
4. Menzies D, Pai M, Comstock G, (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354.
5. Mazurek GH, Villarino ME, (2003) Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 52: 15-18.
6. Nicol MP, Davies MA, Wood K, Hatherill M, Workman L, et al.(2009) Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 123: 38-43.
7. Bianchi L, Galli L, Moriondo M, Veneruso G, Becciolini L, et al.(2009) Interferon-gamma Release Assay Improves the Diagnosis of Tuberculosis in Children. Pediatr Infect Dis J 28: 510-514.
8. Dheda K, Smit RZ, Badri M, Pai M, (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 15: 188-200.
9. Browder AA, Griffon AL, (1972) Tuberculin tine tests on medical wards. Am Rev Respir Dis 105: 299-301.
10. Hansen JP, Falconer JA, Gallis HA, Hamilton JD, (1982) Inadequate sensitivity of tuberculin tine test for screening employee populations. J Occup Med 24: 602-604.
11. Johnson A, Lunn JA, (1978) Comparison of the time and Mantoux tuberculin tests. Br Med J 2: 892.
12. Welke H, Irsigler GB, Kleeberg HH, (1976) The diagnostic value of the tine and Mantoux tests in a general hospital. S Afr Med J 50: 2073-2076.
13. Freiman I, Hartman E, Abkiewicz C, (1976) A comparative study of tuberculin tine and Mantoux tests. S Afr Med J 50: 5-7.
14. Rudd RM, Gellert AR, Venning M, (1982) Comparison of Mantoux, tine, and 'Imotest' tuberculin tests. Lancet 2: 515-518.
15. Sinclair DJ, Johnston RN, (1979) Assessment of tine tuberculin test. Br Med J 1: 1325-1326.
16. Snell NJ, (1979) A comparison of Mantoux and tuberculin Tine testing in a chest unit. Tubercle 60: 99-104.
17. Lunn JA, (1980) Reason for variable response to tine test. Br Med J 280: 223.
18. WHO(2003) Treatment of tuberculosis: Guidelines for national programmes. WHO/CDS/TB/2003313 3rd Edition: Page 63.
19. American Thoracic Society(2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 49: 1-51.
20. Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC)(2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161: S221-247.
21. DOH(2004) The South African National Tuberculosis Control Programme Practical Guidelines 2004.
22. Eilers PH, Borgdorff MW, (2004) Modeling and correction of digit preference in tuberculin surveys. Int J Tuberc Lung Dis 8: 232-239.
23. Black GF, Dockrell HM, Crampin AC, Floyd S, Weir RE, et al.(2001) Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis 184: 322-329.
24. Bailey WC, Gerald LB, Kimerling ME, Redden D, Brook N, et al.(2002) Predictive model to identify positive tuberculosis skin test results during contact investigations. JAMA 287: 996-1002.
25. Ozuah PO, Ozuah TP, Stein RE, Burton W, Mulvihill M, (2001) Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children. JAMA 285: 451-453.
26. Besser RE, Pakiz B, Schulte JM, Alvarado S, Zell ER, et al.(2001) Risk factors for positive mantoux tuberculin skin tests in children in San Diego, California: evidence for boosting and possible foodborne transmission. Pediatrics 108: 305-310.
27. Froehlich H, Ackerson LM, Morozumi PA, (2001) Targeted testing of children for tuberculosis: validation of a risk assessment questionnaire. Pediatrics 107: E54.
28. Joos TJ, Miller WC, Murdoch DM, (2006) Tuberculin reactivity in bacille Calmette-Guerin vaccinated populations: a compilation of international data. Int J Tuberc Lung Dis 10: 883-891.
29. Lienhardt C, Sillah J, Fielding K, Donkor S, Manneh K, et al.(2003) Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa. Pediatrics 111: e608-614.
30. Mudido PM, Guwatudde D, Nakakeeto MK, Bukenya GB, Nsamba D, et al.(1999) The effect of bacille Calmette-Guerin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int J Tuberc Lung Dis 3: 891-895.
31. Rathi SK, Akhtar S, Rahbar MH, Azam SI, (2002) Prevalence and risk factors associated with tuberculin skin test positivity among household contacts of smear-positive pulnionary tuberculosis cases in Umerkot, Pakistan. Int J Tuberc Lung Dis 6: 851-857.
32. Saiman L, San Gabriel P, Schulte J, Vargas MP, Kenyon T, et al.(2001) Risk factors for latent tuberculosis infection among children in New York City. Pediatrics 107: 999-1003.
33. Young J, O'Connor ME, (2005) Risk factors associated with latent tuberculosis infection in Mexican American children. Pediatrics 115: e647-653.
34. Lobato MN, Hopewell PC, (1998) Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis. Am J Respir Crit Care Med 158: 1871-1875.
35. Bener A, Uduman S, Bin-Othman SA, (1996) Factors associated with tuberculin reactivity among children in United Arab Emirates. Respir Med 90: 89-94.
36. Carvalho AC, DeRiemer K, Nunes ZB, Martins M, Comelli M, et al.(2001) Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients. Am J Respir Crit Care Med 164: 2166-2171.
37. Gustafson P, Lisse I, Gomes V, Vieira CS, Lienhardt C, et al.(2007) Risk factors for positive tuberculin skin test in Guinea-Bissau. Epidemiology 18: 340-347.
38. Hawkridge A, Hatherill M, Little F, Goetz MA, Barker L, et al.(2008) Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial. BMJ 337: a2052.
39. Groenewald P BOROWorcester(2004) Boland Overberg Region Annual Health Status Report.
40. WHO(2008) Global tuberculosis control. Country profile. South Africa. http://www.who.int/globalatlas. Accessed 7th October 2008.
41. Hatherill M, Hawkridge T, Zar HJ, Whitelaw A, Tameris M, et al.(2009) Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis? Arch Dis Child 94: 195-201.
42. DOH(2000) The South African National Tuberculosis Control Programme Practical Guidelines 2000.
43. McGinn T, Wyer PC, Newman TB, Keitz S, Leipzig R, et al.(2004) Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 171: 1369-1373.
44. Chan PC, Chang LY, Wu YC, Lu CY, Kuo HS, et al.(2008) Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children. Int J Tuberc Lung Dis 12: 1401-1406.
45. CDC(2005) Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep 54: 1-47.
46. DOH(2008) The South African National Tuberculosis Control Programme Practical Guidelines 2008.
47. Davies GR, Fine PE, Vynnycky E, (2006) Mixture analysis of tuberculin survey data from northern Malawi and critique of the method. Int J Tuberc Lung Dis 10: 1023-1029.
48. Braitstein P, Nyandiko W, Vreeman R, Wools-Kaloustian K, Sang E, et al.(2009) The Clinical Burden of Tuberculosis Among Human Immunodeficiency Virus-Infected Children in Western Kenya and the Impact of Combination Antiretroviral Treatment. Pediatr Infect Dis J 28: 626-632.